Get alerts when CLOV reports next quarter
Set up alerts — freeShares jumped 16.4% post-earnings, reflecting investor approval of Clover Health's 51% year-over-year membership growth and return to GAAP net income profitability, underscoring confidence in the company’s tech-driven care model and scalable Medicare Advantage platform.
See CLOV alongside your other holdings
Add to your portfolio — freeTrack Clover Health Investments, Corp. in your portfolio with real-time analytics, dividend tracking, and more.
View CLOV Analysis